Dimerix Stock

Dimerix Net Debt

The Net Debt of Dimerix (DXB.AX) as of Sep 5, 2026 is -68.19 M AUD. In the previous year, Net Debt was -21.99 M AUD — a change of 210.05% (lower).

Net Debt

-68.19 MAUD

YoY

210.05%

Last updated:

Net Debt of Dimerix is 2026 -68.19 M AUD. Net Debt of Dimerix was 2025 -21.99 M AUD. It decreases by 210.05% lower compared to the previous year.

The Dimerix Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2018
-6.28 M AUD
Jan 1, 2019
-3.56 M AUD
Jan 1, 2020
-6.69 M AUD
Jan 1, 2021
-157,000.00 AUD
Jan 1, 2022
-9.56 M AUD
Jan 1, 2023
-2.03 M AUD
Jan 1, 2024
-21.99 M AUD
Jan 1, 2025
-68.19 M AUD
The Dimerix Net Debt history
YEARNet DebtYoY
-68.19 MAUD+210.05%
-21.99 MAUD+981.21%
-2.03 MAUD-78.72%
-9.56 MAUD+5,987.07%
-157,000.00AUD-97.65%
-6.69 MAUD+87.79%
-3.56 MAUD-43.30%
-6.28 MAUD+179.99%
-2.24 MAUD+11.19%
-2.02 MAUD-31.13%
-2.93 MAUD+144.27%
-1.20 MAUD—
Access this data via the Eulerpool API
Get Free API Key

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Net Debt of Dimerix is -68.19 M AUD in 2026.

Net Debt of Dimerix changed from -21.99 M AUD to -68.19 M AUD, representing a 210.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt Dimerix since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's Dimerix historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Dimerix

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Dimerix